New data on Radium 223 presented at ASCO
June 2, 2013|Internal Medicine News
Author and Disclosure Information
AT THE ASCO ANNUAL MEETING 2013
CHICAGO – Dr. Nicholas Vogelzang, investigator on the ALSYMPCA trial, discusses new data on Radium 223 (Xofigo) and new research on castration-resistant metastatic prostate cancer at the ASCO Annual Meeting 2013.